Issued Patents All Time
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11697850 | Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment | Daniel Chasman, Dov Shiffman | 2023-07-11 |
| 11435363 | Relevance of achieved levels of markers of systemic inflammation following treatment | — | 2022-09-06 |
| 10550433 | Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment | Daniel Chasman, Dov Shiffman | 2020-02-04 |
| 9164104 | Relevance of achieved levels of markers of systemic inflammation following treatment | — | 2015-10-20 |
| 8101363 | Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes | JoAnn E. Manson | 2012-01-24 |
| 7964614 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | Charles H. Hennekens | 2011-06-21 |
| 7943317 | Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment | Daniel Chasman, Dov Shiffman | 2011-05-17 |
| 7189518 | Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases | Uwe Schonbeck, Peter Libby | 2007-03-13 |
| 7030152 | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | Charles H. Hennekens | 2006-04-18 |
| 6040147 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | Charles H. Hennekens | 2000-03-21 |